4-Methyl Erlotinib Hydrochloride
4-Methyl Erlotinib Hydrochloride Basic information
- Product Name:
- 4-Methyl Erlotinib Hydrochloride
- Synonyms:
-
- N-[(3-Ethynyl-4-Methyl)phenyl]-6,7-bis(2-Methoxyethoxy)-4-quinazolinaMine Hydrochloride
- OSI-597
- Erlotinib iMpurity G
- N-(3-ethynyl-4-methylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride
- 4-Methyl Erlotinib Hydrochloride
- N-(3-ETHYNYL-4-METHYLPHENYL)-6,7-BIS(2-METHOXYETHOXY)QUINAZOLIN-4-AMINE HCL
- 4-methyl Erlotinib
- Erlotinib 4-Methyl Analog
- CAS:
- 1346601-52-2
- MF:
- C23H25N3O4
- MW:
- 407.46
- Product Categories:
-
- Amines
- Heterocycles
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Mol File:
- 1346601-52-2.mol
4-Methyl Erlotinib Hydrochloride Chemical Properties
- Melting point:
- 224-228°C (dec.)
- Boiling point:
- 567.5±50.0 °C(Predicted)
- Density
- 1.23±0.1 g/cm3(Predicted)
- storage temp.
- -20°C Freezer
- solubility
- Chloroform (Slightly), DMSO, Methanol (Slightly)
- pka
- 5.33±0.30(Predicted)
- form
- Solid
- color
- Pale Pink to Pale Brown
4-Methyl Erlotinib Hydrochloride Usage And Synthesis
Uses
Erlotinib (E625000) derivative as internal standard for HPLC.
Biological Activity
4-methyl erlotinib is an analog of erlotinib by the addition of a methyl group at the four position of the phenyl group. erlotinib is a tyrosine kinase inhibitor which acts on the epidermal growth factor receptor (egfr) [1].the epidermal growth factor receptor (egfr) autocrine pathway has been important for cancer development and progression, including cell proliferation, apoptosis, angiogenesis, and metastatic spread [2].erlotinib inhibits egfr-associated kinase activity by binding to the egf-activated receptor, with the phenyl group at one end sequestered in a hydrophobic pocket of the kinase domain and the ether linkages at the opposite end projecting into solvent [1].erlotinib can prolong survival in patients with non–small-cell lung cancer after first-line or second-line chemotherapy [3].
References
[1] stamos, j. ,sliwkowski, m.x. and eigenbrot, c. structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. the journal of biological chemisty 277(48), 46265-46272 (2002).
[2] ciardiello f, tortora g. a novel approach in the treatment of cancer: targeting the epidermal growth factor receptor[j]. clinical cancer research, 2001, 7(10): 2958-2970.
[3] shepherd f a, rodrigues pereira j, ciuleanu t, et al. erlotinib in previously treated non–small-cell lung cancer[j]. new england journal of medicine, 2005, 353(2): 123-132.
4-Methyl Erlotinib HydrochlorideSupplier
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- 010-010-52878169 15801002657
- sales@bjcomparison.com
- Tel
- 0510-85629785 18013409632
- sales@reading-chemicals.com
- Tel
- 028-86136736 19130631884
- sales@mic-pharma.com
- Tel
- 0755-89880280
- 3004662104@qq.com
4-Methyl Erlotinib Hydrochloride(1346601-52-2)Related Product Information
- Erlotinib iMpurity 2
- Erlotinib iMpurity 3
- 2,3,5-Trimethylpyridine-1-Oxide
- Ethyl 3,4-dihydroxybenzoate
- 3-Ethynylaniline
- 6,7-bis(2-methoxyethoxy)-N-phenylquinazolin-4-amine
- Erlotinib iMpurity
- 6,7-Bis-(2-methoxyethoxy)-4(3H)-quinazolinone
- 4-Chloro-6,7-bis-(2-chloroethoxy)quinazoline
- Erlotinib hydrochloride
- Desmethyl Erlotinib Acetate
- OSI-420
- Erlotinib
- Erlotinib Impurity 20
- 4-Quinazolinamine,N-(3-ethenylphenyl)-6,7-bis(2-methoxyethoxy)-,hydrochloride(1:1)
- Erlotinib
- Erlotinib D6 HCl
- Didesmethyl Erlotinib Hydrochloride Salt